Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans
Phase 1
Completed
- Conditions
- Insulin Resistance, Diabetes
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Housey Healthcare ULC
- Target Recruit Count
- 22
- Registration Number
- NCT03135015
- Locations
- 🇨🇦
Glycemic Index Laboratories, Inc., Toronto, Ontario, Canada
News
No news found